Limits...
APF, HB-EGF, and EGF biomarkers in patients with ulcerative vs. non-ulcerative interstitial cystitis.

Zhang CO, Li ZL, Kong CZ - BMC Urol (2005)

Bottom Line: APF activity (inhibition of thymidine incorporation) was significantly greater in all IC patient urine specimens than in normal control specimens or in specimens from patients with bacterial cystitis or bladder cancer (p < 0.0001 for each comparison).Urine HB-EGF levels were also significantly lower and EGF levels significantly higher in both groups of IC patients than in the three control groups (p < 0.0001 for each comparison).Although APF and HB-EGF levels were similar in ulcerative and nonulcerative IC patients, EGF levels were significantly higher in IC patients with vs. without ulcers (p < 0.004).

View Article: PubMed Central - HTML - PubMed

Affiliation: Division of Infectious Diseases, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD 21201, USA. czhan001@umaryland.edu

ABSTRACT

Background: Interstitial cystitis (IC) is a chronic bladder disorder, with symptoms including pelvic and or perineal pain, urinary frequency, and urgency. The etiology of IC is unknown, but sensitive and specific biomarkers have been described, including antiproliferative factor (APF), heparin-binding epidermal growth factor-like growth factor (HB-EGF), and epidermal growth factor (EGF). However, the relative sensitivity of these biomarkers in ulcerative vs. nonulcerative IC is unknown, and these markers have yet to be validated in another laboratory. We therefore measured these markers in urine from patients with or without Hunner's ulcer, as well as normal controls, patients with bladder cancer, and patients with bacterial cystitis, at the First Hospital of China Medical University.

Methods: Urine specimens were collected from two groups of Chinese IC patients (38 IC patients with Hunner's ulcers, 26 IC patients without Hunner's ulcers), 30 normal controls, 10 bacterial cystitis patients and 10 bladder cancer patients. APF activity was determined by measuring 3H-thymidine incorporation in vitro, and HB-EGF and EGF levels were determined by ELISA.

Results: APF activity (inhibition of thymidine incorporation) was significantly greater in all IC patient urine specimens than in normal control specimens or in specimens from patients with bacterial cystitis or bladder cancer (p < 0.0001 for each comparison). Urine HB-EGF levels were also significantly lower and EGF levels significantly higher in both groups of IC patients than in the three control groups (p < 0.0001 for each comparison). Although APF and HB-EGF levels were similar in ulcerative and nonulcerative IC patients, EGF levels were significantly higher in IC patients with vs. without ulcers (p < 0.004).

Conclusion: These findings indicate that APF, HB-EGF and EGF are good biomarkers for both ulcerative and nonulcerative IC and validate their measurement as biomarkers for IC in Chinese patients.

Show MeSH

Related in: MedlinePlus

HB-EGF levels in urine from IC patients, normal controls, bacterial cystitis patients and bladder cancer patients. HB-EGF levels were measured by ELISA in urine specimens from interstitial cystitis patients with Hunner's ulcers (IC-U), interstitial cystitis patients without Hunner's ulcers (IC-N), asymptomatic controls (Ctr), and patients with bacterial cystitis (BC), or bladder cancer (BCa). Each data point is the mean value for duplicate specimens. Horizontal line indicates value of mean; vertical line indicates standard error of mean for each group.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC1131910&req=5

Figure 2: HB-EGF levels in urine from IC patients, normal controls, bacterial cystitis patients and bladder cancer patients. HB-EGF levels were measured by ELISA in urine specimens from interstitial cystitis patients with Hunner's ulcers (IC-U), interstitial cystitis patients without Hunner's ulcers (IC-N), asymptomatic controls (Ctr), and patients with bacterial cystitis (BC), or bladder cancer (BCa). Each data point is the mean value for duplicate specimens. Horizontal line indicates value of mean; vertical line indicates standard error of mean for each group.

Mentions: We next measured HB-EGF and EGF levels in urine specimens from the same Chinese IC patients, normal controls, bacterial cystitis patients and bladder cancer patients by ELISA. As shown in Figure 2, the concentration of urine HB-EGF was significantly lower in the 38 IC patients with Hunner's ulcers (1.19 ± 0.20 ng/ml) and in the 26 IC patients without Hunner's ulcers (1.42 ± 0.23 ng/ml) as compared to normal controls (9.28 ± 1.04 ng/ml) or patients with bacterial cystitis or bladder cancer (5.34 ± 1.19 ng/ml, and 5.72 ± 0.87 ng/ml, p < 0.0001 for comparison of each IC group to each control group). Mean HB-EGF levels in the two groups of IC patients did not differ significantly from each other (p = 0.43). The mean concentration of urine EGF (Figure 3), however, was significantly higher in 38 IC patients with Hunner's ulcers (21.90 ± 1.19 ng/ml) than in 26 IC patients without Hunner's ulcers (16.32 ± 1.44 ng/ml) (p <0.004), and was markedly higher for both IC groups as compared to normal controls (6.49 ± 0.57 ng/ml) or patients with bacterial cystitis or bladder cancer (6.32 ± 1.26 ng/ml, and 8.03 ± 1.95 ng/ml, p < 0.0001 for comparison of each IC group to each control group).


APF, HB-EGF, and EGF biomarkers in patients with ulcerative vs. non-ulcerative interstitial cystitis.

Zhang CO, Li ZL, Kong CZ - BMC Urol (2005)

HB-EGF levels in urine from IC patients, normal controls, bacterial cystitis patients and bladder cancer patients. HB-EGF levels were measured by ELISA in urine specimens from interstitial cystitis patients with Hunner's ulcers (IC-U), interstitial cystitis patients without Hunner's ulcers (IC-N), asymptomatic controls (Ctr), and patients with bacterial cystitis (BC), or bladder cancer (BCa). Each data point is the mean value for duplicate specimens. Horizontal line indicates value of mean; vertical line indicates standard error of mean for each group.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC1131910&req=5

Figure 2: HB-EGF levels in urine from IC patients, normal controls, bacterial cystitis patients and bladder cancer patients. HB-EGF levels were measured by ELISA in urine specimens from interstitial cystitis patients with Hunner's ulcers (IC-U), interstitial cystitis patients without Hunner's ulcers (IC-N), asymptomatic controls (Ctr), and patients with bacterial cystitis (BC), or bladder cancer (BCa). Each data point is the mean value for duplicate specimens. Horizontal line indicates value of mean; vertical line indicates standard error of mean for each group.
Mentions: We next measured HB-EGF and EGF levels in urine specimens from the same Chinese IC patients, normal controls, bacterial cystitis patients and bladder cancer patients by ELISA. As shown in Figure 2, the concentration of urine HB-EGF was significantly lower in the 38 IC patients with Hunner's ulcers (1.19 ± 0.20 ng/ml) and in the 26 IC patients without Hunner's ulcers (1.42 ± 0.23 ng/ml) as compared to normal controls (9.28 ± 1.04 ng/ml) or patients with bacterial cystitis or bladder cancer (5.34 ± 1.19 ng/ml, and 5.72 ± 0.87 ng/ml, p < 0.0001 for comparison of each IC group to each control group). Mean HB-EGF levels in the two groups of IC patients did not differ significantly from each other (p = 0.43). The mean concentration of urine EGF (Figure 3), however, was significantly higher in 38 IC patients with Hunner's ulcers (21.90 ± 1.19 ng/ml) than in 26 IC patients without Hunner's ulcers (16.32 ± 1.44 ng/ml) (p <0.004), and was markedly higher for both IC groups as compared to normal controls (6.49 ± 0.57 ng/ml) or patients with bacterial cystitis or bladder cancer (6.32 ± 1.26 ng/ml, and 8.03 ± 1.95 ng/ml, p < 0.0001 for comparison of each IC group to each control group).

Bottom Line: APF activity (inhibition of thymidine incorporation) was significantly greater in all IC patient urine specimens than in normal control specimens or in specimens from patients with bacterial cystitis or bladder cancer (p < 0.0001 for each comparison).Urine HB-EGF levels were also significantly lower and EGF levels significantly higher in both groups of IC patients than in the three control groups (p < 0.0001 for each comparison).Although APF and HB-EGF levels were similar in ulcerative and nonulcerative IC patients, EGF levels were significantly higher in IC patients with vs. without ulcers (p < 0.004).

View Article: PubMed Central - HTML - PubMed

Affiliation: Division of Infectious Diseases, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD 21201, USA. czhan001@umaryland.edu

ABSTRACT

Background: Interstitial cystitis (IC) is a chronic bladder disorder, with symptoms including pelvic and or perineal pain, urinary frequency, and urgency. The etiology of IC is unknown, but sensitive and specific biomarkers have been described, including antiproliferative factor (APF), heparin-binding epidermal growth factor-like growth factor (HB-EGF), and epidermal growth factor (EGF). However, the relative sensitivity of these biomarkers in ulcerative vs. nonulcerative IC is unknown, and these markers have yet to be validated in another laboratory. We therefore measured these markers in urine from patients with or without Hunner's ulcer, as well as normal controls, patients with bladder cancer, and patients with bacterial cystitis, at the First Hospital of China Medical University.

Methods: Urine specimens were collected from two groups of Chinese IC patients (38 IC patients with Hunner's ulcers, 26 IC patients without Hunner's ulcers), 30 normal controls, 10 bacterial cystitis patients and 10 bladder cancer patients. APF activity was determined by measuring 3H-thymidine incorporation in vitro, and HB-EGF and EGF levels were determined by ELISA.

Results: APF activity (inhibition of thymidine incorporation) was significantly greater in all IC patient urine specimens than in normal control specimens or in specimens from patients with bacterial cystitis or bladder cancer (p < 0.0001 for each comparison). Urine HB-EGF levels were also significantly lower and EGF levels significantly higher in both groups of IC patients than in the three control groups (p < 0.0001 for each comparison). Although APF and HB-EGF levels were similar in ulcerative and nonulcerative IC patients, EGF levels were significantly higher in IC patients with vs. without ulcers (p < 0.004).

Conclusion: These findings indicate that APF, HB-EGF and EGF are good biomarkers for both ulcerative and nonulcerative IC and validate their measurement as biomarkers for IC in Chinese patients.

Show MeSH
Related in: MedlinePlus